Redmond Oregon based TriAgenics is raising $2,502,500.00 in New Equity Investment.
Redmond, OR – According to filings with the U.S. Securities and Exchange Commission, TriAgenics is raising $2,502,500.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Leigh Colby played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About TriAgenics
TriAgenics Zero3 TBA one-minute procedure is designed to gently warm just the center of the developing wisdom tooth buds. In multiple live animal trials to date there has been no observed adverse outcomes other than one post-op infection. TriAgenics Zero3 TBA one-minute procedure is designed to predictably block wisdom tooth formation. In limited live animal trials to date there has been zero detectable tooth formation following 3TBA.
To learn more about TriAgenics, visit http://triagenics.com/
Contact:
Leigh Colby, President and Chief Executive Officer
541-527-1800
SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved